drugset / Trial / NCT04295993

Methylene Blue and Microcirculation in Septic Shock

NCT04295993

Phase 3 Unknown 32 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial aims to identify the effects of methylene blue infusion on the the micro-circulation in patients with septic shock. The investigators will evaluate various indices of micro-circulation such as: microvascular flow index, the flow heterogeneity index, the total vessel density, the perfused vessel density, and the proportion of perfused vessels.

Timeline

Start
2020-03-10
Primary completion
2020-09-10
Completion
2020-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent 2 mg/kg
Background Norepinephrine Other / unclassified